![Gregory Conn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Conn
Technik-/Wissenschafts-/F&E-Leiter bei
PDS BIOTECHNOLOGY CORPORATION
Vermögen: 108 882 $ am 30.06.2026
Profil
Gregory L.
Conn is the founder of PDS Operating Corp.
Dr. Conn is Chief Scientific Officer at PDS Biotechnology Corp.
since 2005.
Dr. Conn was Director of the Process Development Department at Covance Biotechnology Services, Inc. from 1998 to 2000.
Dr. Conn completed graduate and doctorate degrees at Albert Einstein College of Medicine, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PDS BIOTECHNOLOGY CORP. 0,22 % | 12.01.2026 | 123.589 ( 0,22 % ) | 108 882 $ | 30.06.2026 |
Aktive Positionen von Gregory Conn
| Unternehmen | Position | Beginn |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 |
Ehemalige bekannte Positionen von Gregory Conn
| Unternehmen | Position | Ende |
|---|---|---|
Covance Biotechnology Services, Inc.
 Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01.01.2000 |
PDS Operating Corp.
 PDS Operating Corp. Pharmaceuticals: MajorHealth Technology Develops novel cancer immunotherapies and vaccines for infectious disease | Gründer | - |
Ausbildung von Gregory Conn
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
30
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
PDS Operating Corp.
PDS Operating Corp. Pharmaceuticals: MajorHealth Technology Develops novel cancer immunotherapies and vaccines for infectious disease | Health Technology |
Covance Biotechnology Services, Inc.
Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDS Biotechnology Corp.
 PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers | Health Technology |
